Wegovy Arrives in Spain in Pills: the First Oral Treatment with LPG-1 to Lose Weight
13 Articles
13 Articles
Oral Wegovy is now sold in pharmacies for 236.20 euros per month, with a medical prescription and without public funding
Novo Nordisk lanzá in Spain the "only GLP-1 recepto agonist in oral format" of the same family as Ozempic and that, "with interventions on lifestyle", causes weight loss of 17%Ozempic is consolidated as the most funded drug by public health The company Novo Nordisk has presented this Tuesday in Spain the first Wegovy pill, the drug for weight control that was already available in injectable format. It is the "only GLP-1 receptor agonist in oral …
informacion.es
The drug Wegovy, used to treat obesity and overweight, is already available in Spanish pharmacies in pill format. The pharmaceutical company Novo Nordisk announced on Tuesday, November 3 that the oral version of this treatment, whose active substance is semaglutide, has been available in the country since November 1.
The first GLP-1-receptor agonist in tablets for the treatment of obesity is now available in Spain. For many more known as the first in the family...
Spain is the fifth country in the world where Wegovy is available, subject to medical prescription and, for the time being, without public funding.
People with obesity or overweight already have at their fingertips oral Wegovy, the first agonist of...
Coverage Details
Bias Distribution
- 43% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
